Noom GLP-1 Companion

Improve adherence. Boost outcomes. Maximize ROI.

Noom GLP-1 Companion paves the way to success for those taking GLP-1 medications, offering ongoing comprehensive support during and after their weight loss journey, leading to lasting health outcomes and lower overall costs.

Noom GLP-1 Companion hero

Tailored lifestyle support for greater GLP-1 effectiveness.

Many people taking GLP-1 medications lack the adequate support needed to make the necessary lifestyle changes to achieve long term success. Noom’s GLP-1 Companion provides members with the tools and support they need throughout their medication journey, to reach their health goals and maximize ROI.

Noom GLP-1 Companion product app screenshot

MAXIMIZING WEIGHT LOSS SUCCESS

Noom provides personalized lifestyle guidance and tools that enhance the effectiveness of GLP-1 medications, helping members achieve long term results.

SUSTAINED RESULTS THROUGH TAILORED BEHAVIOR CHANGE

Our program uses proven behavior change strategies to support members throughout their entire medication journey.

BOOSTING ADHERENCE TO REDUCE GLP-1 WASTAGE

We help members face and overcome the challenges that come with adhering to GLP-1 therapy, allowing them to maximize its benefits and reduce the financial waste of early discontinuation.

Noom’s GLP-1 support makes long term health a reality.

PROTEIN POWER

High-protein recipes and protein-tracking features help members prevent muscle loss, a common side effect of GLP-1 medications.

Noom GLP-1 Companion app — Protein Power feature

Real support leads to real results.

Proven outcomes in 50+ peer-reviewed publications and 10+ academic medical research collaborations.

39%

more weight loss reported compared to a GLP-1 alone1

91%

of users who added Noom to a GLP-1 reported Noom had a positive impact on their success2

70%

agreed that Noom was life-changing3

Noom is closing the GLP-1 care gap.

The all-in-one solution to healthy living and lower costs.

Bring Noom to your organization today.

  1. Cleveland Clinic. “Prediabetes.” ↩︎
  2. Noom internal retrospective analysis of data from 2021–2022. ↩︎
  3. Usefulness of a novel mobile Diabetes Prevention Program delivery platform with human coaching. May 2018. An engaged user is defined as a participant who completed the 24-week intervention and took any in-app action during the maintenance phase (weeks 24–65). ↩︎